It is hard to keep up with complex diseases and therapy options. Current gaps in knowledge, together with the rapid pace of research and the abundance of existing information, make it difficult to have the best understanding needed for pre-clinical and clinical development decisions. Biovista constantly updates its drug-target-disease-Adverse Event profiling with concise meta-reviews that are specifically aimed at identifying knowledge gaps. We compile the latest data from clinical trials and trends in a single reference document that is updated regularly and on demand.

Click Here to see a list of our Meta-Reviews

Click Here to see our sample Executive Summary and Table of Contents for Melanoma.

To find out more about our Meta-review and Gap Analysis service please contact us.